跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,537 条关于
“Sanofi Regeneron”
全部
1,537
临床试验
162
药物
303
机构
65
资讯
1,007
2年前
FDA Nears Decisions on Vanda, Zevra, Heron, Merck, BMS, Sanofi/Regeneron
2年前
FDA Nears Decisions on Key Therapies for Gastroparesis, Niemann-Pick Disease, Schizophrenia, COPD, Mesothelioma, and Post-Surgical Pain
去年
Dupixent Approved for COPD: A New Era in Targeted Therapy
去年
Dupixent Gains Momentum: EU Approvals for Eosinophilic Esophagitis and COPD, US Approval for COPD
去年
Sanofi and Regeneron Announce AIM4 Trial to Advance Personalized Asthma Treatment
去年
UPC Sets Precedent in First Second Medical Use Patent Ruling: Sanofi and Regeneron Lose Against Amgen
去年
Viz.ai Partners with Sanofi and Regeneron to Deploy AI-Powered COPD Management Solution
去年
Dupixent Shows Positive Phase 3 Results in Chronic Spontaneous Urticaria
9个月前
Sanofi and Regeneron Launch Real-World Studies to Strengthen Dupilumab's Evidence Base Across Multiple Inflammatory Conditions
去年
EMA Approves Dupixent for Eosinophilic Esophagitis in Young Children
第 1 页,共 101 页
上一页
下一页